Dr. Lungu has over 30 years’ experience in drug development, clinical research, Pharmacovigilance and quality assurance. He conducted more than 160 Pharmacovigilance quality system audits in more than 40 countries around the globe. Apart of audits, he is a dedicated trainer of the official EMA EudraVigilance and XEVMPD training programmes and led over 300 offerings since 2004.

Ana has worked 13 years in the Directorate of Risk Management for Medicines of the Portuguese medicines competent authority INFARMED. Until 2013, she was Responsible Person for EudraVigilance and member of the EudraVigilance Expert Working Group and EudraVigilance Telematics Implementation Group. Between 2013 and 2015, Ana was INFARMED’s Executive Board adviser responsible for managing the National Pharmacy and Therapeutic Committee. Since 2015, she has been working with consumption and prescription data on medicinal products, analysing trends in medicines’ prescription and use in Portugal. Ana has extensive experience as a trainer in pharmacovigilance and EudraVigilance since 2003.